No black box warning on record for Clotrimazole And Betamethasone Dipropionate

As of the latest FDA labeling reviewed, Clotrimazole And Betamethasone Dipropionate (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Clotrimazole And Betamethasone Dipropionate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Clotrimazole and betamethasone dipropionate cream can cause reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency during and after withdrawal of the treatment. Risk factor(s) are: use of high-potency topical corticosteroid, use over a large surface area or to areas under occlusion, prolonged use, altered skin barrier, liver failure, and

No black box warning on record for Clotrimazole And Betamethasone Dipropionate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Clotrimazole and betamethasone dipropionate cream can cause reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency during and after withdrawal of the treatment. Risk factor(s) are: use of high-potency topical corticosteroid, use over a large surface area or to areas under occlusion, prolonged use, altered skin barrier, liver failure, and

Clotrimazole And Betamethasone Dipropionate Black Box Warning

No black box warning on record for Clotrimazole And Betamethasone Dipropionate

Other warnings & precautions

Clotrimazole And Betamethasone Dipropionate Black Box Warning

No black box warning on record for Clotrimazole And Betamethasone Dipropionate

Other warnings & precautions